Ineffective Tissue Perfusion Nursing Diagnosis: 5 Sample Care Plans & Interventions

Choosing the right ineffective tissue perfusion nursing diagnosis — and building a clean NANDA-I care plan around it — is one of those topics that shows up over and over: post-op patients, stroke patients, the MI on telemetry, the septic patient on pressors, the diabetic with a cold pulseless foot, the AFib patient with abdominal pain.

Anywhere blood isn’t getting where it needs to go, you’re dealing with a perfusion problem. This ineffective tissue perfusion care plan walks through what to assess, the current NANDA-I 2024–2026 nursing diagnoses for ineffective tissue perfusion (the labels changed — more on that below), and 5 sample care plans you can model your clinical paperwork on for cardiac, cerebral, kidney, peripheral, and gastrointestinal perfusion.

It’s written for nursing students, new grads, and any RN who wants a refresher with current NANDA-I 2024–2026 language, 2025 ACC/AHA ACS framing, and current stroke / PAD / AKI guidance baked in.

Scope note. This is an educational care plan for nursing students and new graduates. It is not a substitute for facility protocol, provider orders, or specialist clinical judgment. Time-sensitive emergencies like acute stroke, STEMI, acute limb ischemia, and mesenteric ischemia depend on rapid escalation, imaging, and specialty consult — always follow your institution’s policy and the patient’s individualized plan of care.

Table of contents

• What is ineffective tissue perfusion?
• NANDA-I 2024–2026 — the labels changed
• Causes by system
• Signs and symptoms
• Nursing assessment
• Diagnostic studies and lab interpretation
• Lactate as a perfusion marker
• Nursing goals and outcomes
• Nursing interventions
• Ineffective tissue perfusion nursing diagnosis — 5 sample care plans
• Stroke at the bedside (BE FAST, NIHSS, treatment windows)
• Acute limb ischemia (the 6 Ps)
• Escalation red flags
• Discharge and patient teaching
• Practice question
• FAQs
• Related resources
• References

What is ineffective tissue perfusion?

Ineffective tissue perfusion is a problem with the delivery of oxygenated blood to tissues, whether from a pump problem (cardiac), a pipe problem (vascular obstruction or constriction), a volume problem (hypovolemia), or a content problem (severe anemia, hypoxemia). Adequate perfusion depends on three things working together:

1. Mean arterial pressure (MAP) — the driving pressure pushing blood through the capillary bed. MAP ≥ 65 mm Hg is a common initial target in septic shock and many critical-care contexts (per Surviving Sepsis Campaign 2021), but it is not a universal “adequate perfusion” guarantee. Trend other markers — urine output, mentation, lactate, skin findings, organ function — alongside the MAP number. Individualized targets may be higher (chronic hypertension) or different per provider order.
2. Blood oxygen content — adequate hemoglobin, adequate SpO₂.
3. Vascular patency — no occlusion (clot, plaque, embolism), no severe vasoconstriction, no shunt.

When any of those break down for long enough, tissues hypoperfuse, oxygen demand outstrips supply, anaerobic metabolism produces lactate, and end-organ injury follows. The system that fails first depends on the cause and the patient — the brain in stroke, the myocardium in MI, the kidney in shock, the limb in acute occlusion, the gut in AFib-related mesenteric embolus.

NANDA-I 2024–2026 — the labels changed

This is important and not always reflected in older articles. Current NANDA-I editions emphasize system-specific perfusion-related diagnoses rather than a single generic “Ineffective Tissue Perfusion” label. The perfusion-related labels you’ll most often see in clinical paperwork (verify exact wording in your licensed NANDA-I 2024–2026 text before using for graded paperwork):

NANDA verification. Labels, definitions, defining characteristics, and related / risk factors are updated by edition. Verify the exact wording against your licensed NANDA-I 2024–2026 text before using these for graded clinical paperwork. If your institution still uses an older edition with the generic “Ineffective Tissue Perfusion” label, follow your facility’s documentation standard but understand that the current NANDA-I direction is system-specific.

The 5 sample care plans below are mapped to these current labels.

Causes by system

Cardiac perfusion problems

• Acute coronary syndrome (STEMI, NSTEMI, unstable angina), coronary spasm, dissection, severe aortic stenosis
• Cardiogenic shock from any cause (post-MI, decompensated HF, severe valve disease, cardiomyopathy)

Cerebral perfusion problems

• Ischemic stroke (large-vessel occlusion, small-vessel, cardioembolic from AFib)
• Hemorrhagic stroke (intracerebral, subarachnoid)
• TIA, transient global hypoperfusion (syncope), severe carotid stenosis
• Elevated ICP from any cause (trauma, mass, edema, hemorrhage)

Kidney perfusion problems

• Pre-renal AKI from hypovolemia (bleeding, dehydration, GI losses, burns)
• Septic shock, cardiogenic shock with renal under-perfusion
• Renal artery stenosis (especially bilateral) — ACE inhibitors / ARBs can worsen function
• Intra-abdominal hypertension / abdominal compartment syndrome

Peripheral perfusion problems

• Peripheral artery disease (PAD) — atherosclerotic narrowing
• Acute limb ischemia — embolic (often from AFib), thrombotic, or post-arterial-line complication
• DVT — venous obstruction
• Severe peripheral vasoconstriction (shock, vasopressor effect, hypothermia)
• Diabetic vascular disease — small-vessel and large-vessel

GI perfusion problems

• Acute mesenteric ischemia — embolic (AFib), thrombotic, low-flow state
• Mesenteric venous thrombosis
• Post-cardiac-surgery low-flow state
• GI hemorrhage with hypovolemia

Signs and symptoms

By organ system. The data below is what to consider, not what every patient will have.

Cardiac perfusion problems

• Chest pain (substernal, may radiate to jaw, arm, back, epigastrium; women, elderly, and people with diabetes may have atypical presentations — dyspnea, fatigue, indigestion)
• Diaphoresis, nausea
• ST changes on ECG; troponin elevation
• New heart failure signs, S3, crackles

Cerebral perfusion problems

• Sudden focal neurologic deficit — facial droop, arm weakness, slurred speech (use BE FAST — see below)
• Confusion, altered mental status
• Severe sudden headache (think hemorrhagic until ruled out)
• Vision changes (monocular blindness in carotid disease, hemianopia in stroke)
• Vertigo, ataxia (posterior circulation stroke)

Kidney perfusion problems

• Decreased urine output (< 0.5 mL/kg/hr or < 30 mL/hr)
• Rising creatinine, rising BUN, hyperkalemia
• Volume status signs — orthostasis, dry mucous membranes, low CVP

Peripheral perfusion problems

• Intermittent claudication (walking-induced calf pain that resolves with rest)
• Rest pain (later stage; often at night, relieved by dangling)
• Cool, pale, or cyanotic extremity
• Diminished or absent pulses; capillary refill > 3 seconds; trophic skin changes (hair loss, shiny skin, thickened nails)
• Acute limb ischemia: the 6 Ps — Pain, Pallor, Pulselessness, Paresthesia, Paralysis, Poikilothermia (cold limb)

GI perfusion problems

• Sudden severe abdominal pain
• Classic finding: “pain out of proportion to physical exam” — patient writhing in pain with relatively benign abdominal exam in early phase
• Nausea, vomiting, diarrhea (sometimes bloody)
• Lactic acidosis trending up
• Later: peritoneal signs, sepsis, shock

Nursing assessment

A solid assessment is what makes the difference between a generic care plan and one with the right ineffective tissue perfusion nursing diagnosis attached to it. Use a structured approach. The data below is what to consider, not what every patient will have.

Subjective data

• Onset and pattern of pain, weakness, neurologic change
• History — known CAD, AFib, HF, PAD, prior stroke / TIA, diabetes, smoking, hyperlipidemia
• Medication review — anticoagulants, antiplatelets, antihypertensives, vasodilators, vasopressors
• Functional status — claudication distance, ADL tolerance, baseline neurologic function
• Last known well — critical for stroke window decisions

Objective data

• Vital signs (HR, BP, MAP, SpO₂); orthostatic vitals when relevant
• Heart sounds, lung sounds, peripheral pulses (compare side to side)
• Neuro exam — alertness, orientation, cranial nerves, motor strength, sensation, gait if safe, NIHSS if stroke suspected
• Capillary refill, skin color and temperature, sensation in extremities
• Abdomen — inspection, auscultation, palpation, peritoneal signs
• Urine output (hourly when indicated)
• ECG, telemetry rhythm strip
• Lab and imaging trend review

Avoid absolute language. “Capillary refill 4 seconds in the right foot” is more useful than “perfusion is poor.” Document what you observe.

Diagnostic studies and lab interpretation

A1C, lipids, hypercoagulable workup, and rheumatology labs are added depending on the underlying mechanism. Reference ranges vary by lab — check facility normals.

Lactate as a perfusion marker

Lactate is one of the most useful bedside markers for impaired perfusion:

• Normal: < 2 mmol/L
• > 2 mmol/L: Concerning — prompt reassessment in clinical context. Causes include sepsis, shock, regional ischemia, severe exertion, seizures, metformin retention, beta-agonist use, liver dysfunction
• ≥ 4 mmol/L: High-risk finding often seen in shock or severe illness, but not specific for hypoperfusion. Interpret with the perfusion exam, hemodynamics, medications, liver function, recent seizures or exertion, sepsis screening, and regional-ischemia risk in mind
• Trending: A falling lactate during resuscitation suggests improving perfusion; a stable or rising lactate despite intervention suggests inadequate resuscitation or ongoing injury. Trending matters more than a single value.

In sepsis bundles, an initial lactate ≥ 2 mmol/L typically triggers serial measurement and a target of lactate clearance with treatment.

Nursing goals and outcomes

Once you’ve picked the ineffective tissue perfusion nursing diagnosis that fits the patient’s actual presentation, your goals flow directly from it. By the end of the shift / hospitalization, the patient will (choose what fits the individual patient):

• Maintain MAP ≥ 65 mm Hg (or the individualized target ordered by the provider).
• Maintain SpO₂ within the patient’s individualized target range.
• Maintain urine output ≥ 0.5 mL/kg/hr (or ≥ 30 mL/hr).
• Demonstrate trending improvement in the perfusion marker that matters for the patient — lactate trending down, neurologic exam improving (NIHSS), troponin plateauing, ABI improving with revascularization, capillary refill normalizing.
• Verbalize three early signs of worsening perfusion specific to their diagnosis (stroke recognition with BE FAST, chest pain return, sudden cold/pale/painful limb, new abdominal pain, decreased urine output).
• Identify three lifestyle or medication changes appropriate to their underlying risk (smoking cessation, BP control, statin adherence, anticoagulant adherence, glycemic control, walking program for PAD).
• Remain free of new perfusion-related injury (new infarct, limb loss, AKI progression).

Use SMART framing and add function-based goals where possible — “walks 100 feet without claudication pain” is more useful than “tolerates activity.”

Nursing interventions

General perfusion support

• Monitor vital signs and MAP per facility protocol; recognize trends, not just single values.
• Maintain SpO₂ ≥ 92% (or per provider target). Apply oxygen for hypoxemia. Routine oxygen for non-hypoxic ACS or stroke is not indicated per current guidance.
• Maintain euvolemia — neither dry (under-perfusing) nor overloaded.
• Trend lactate, urine output, mental status, and the system-specific markers.

Cardiac perfusion

• Continuous telemetry; serial ECGs and troponins per provider order.
• For STEMI: facilitate first-medical-contact-to-device ≤ 90 minutes (PCI) or door-to-needle ≤ 30 minutes (fibrinolytics if PCI unavailable) per the 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS guideline.
• Administer antiplatelets, anticoagulants, statins, beta-blockers, and other ACS medications per provider order.
• Position upright if hemodynamics allow; supplemental oxygen for hypoxia or respiratory distress (not routinely).

Cerebral perfusion

• Frequent neuro checks (NIHSS or facility-standardized scale) per provider order; document last known well.
• Non-contrast head CT before aspirin or any anticoagulation — hemorrhagic stroke and aspirin do not mix.
• Permissive hypertension for ischemic stroke (typically allow SBP up to ~220 / 120 if not receiving IV thrombolysis, lower for thrombolysis candidates per the 2026 AHA/ASA guideline) — confirm targets with the stroke team.
• HOB per stroke-team order and facility protocol. Consider airway protection, aspiration risk, oxygenation, ICP concerns, hemodynamics, and patient tolerance. The benefit of routine flat-head positioning early after ischemic stroke is uncertain per AHA/ASA — don’t assume flat is the default.
• NPO until swallow screen is passed.

Kidney perfusion

• Hourly urine output; target ≥ 0.5 mL/kg/hr.
• Monitor BUN, creatinine, K⁺ trends; recognize KDIGO AKI stages.
• Review nephrotoxic medications (NSAIDs, aminoglycosides, IV contrast, ACEi/ARB in bilateral renal artery stenosis); notify the provider and hold only per provider order or facility protocol.
• IV fluids per provider order for hypovolemia; vasopressors per provider for septic / cardiogenic shock.
• Do not delay time-sensitive CTA for stroke, acute limb ischemia, or acute mesenteric ischemia solely because creatinine is elevated. In these emergencies, the risk of a missed or delayed diagnosis outweighs the contrast risk. Avoid nonurgent nephrotoxic exposure; hydrate before / after contrast when clinically appropriate.

Peripheral perfusion

• Compare pulses bilaterally each shift (DP, PT, popliteal, femoral); document quality.
• Assess capillary refill, skin color, temperature, sensation, motor function — comparison side to side.
• For PAD: walking program education (claudication-paced exercise can improve symptoms); smoking cessation; statins; antiplatelet therapy per provider.
• For suspected acute limb ischemia (6 Ps): vascular surgery emergency — same-shift escalation.
• Position dependent for arterial insufficiency, elevated for venous insufficiency / DVT (verify with provider).

Gastrointestinal perfusion

• Recognize “pain out of proportion to exam” — escalate.
• Monitor lactate, lipase, abdominal exam serially.
• NPO until cleared.
• Coordinate CT angio per provider order; vascular surgery / GI consult early.

Education

• Reinforce when to call 911 vs. provider vs. clinic for the patient’s specific risk.
• Link to nursing diagnosis and nursing interventions for student-facing context.

Ineffective tissue perfusion nursing diagnosis — 5 sample care plans

These five care plans cover the nursing diagnoses for ineffective tissue perfusion you’ll see most often in clinical paperwork. Each uses NANDA-I-style nursing diagnosis language mapped to the current 2024–2026 system-specific labels, current clinical guidance (2025 ACC/AHA ACS, AHA stroke 2024, KDIGO AKI), and the standard student template (diagnosis → defining characteristics / risk factors → goals → interventions with rationales → evaluation).

NANDA-I label verification. Verify the exact label, definition, and defining characteristics against your licensed NANDA-I 2024–2026 text before using these for graded clinical paperwork. If your institution still uses an older edition with the generic “Ineffective Tissue Perfusion” label, document per your facility’s standard.

Care Plan #1 — Risk for Decreased Cardiac Tissue Perfusion

Scenario. A 64-year-old man presents to the ED with substernal chest pain radiating to the left arm, diaphoresis, and dyspnea for 90 minutes. HR 102, BP 142/88, SpO₂ 96% on room air. ECG shows ST elevation in II, III, and aVF (inferior STEMI). Troponin pending.

Diagnosis (NANDA-I 2024–2026)

Risk for Decreased Cardiac Tissue Perfusion related to acute coronary thrombosis with ST-elevation myocardial infarction (inferior wall), acute oxygen supply–demand mismatch, and underlying coronary artery disease.

(Risk-for diagnoses use “related to” only — no “as evidenced by.”)

Goals

• For STEMI managed with primary PCI, target first-medical-contact-to-device time ≤ 90 minutes when feasible in a PCI-capable system per the 2025 ACC/AHA ACS guideline. If timely PCI cannot be achieved and there are no contraindications, fibrinolysis may be used per protocol with a door-to-needle goal ≤ 30 minutes.
• Within 24 hours, the patient is free of recurrent chest pain and arrhythmia, troponin peaks and trends down.
• Pre-discharge, the patient verbalizes ACS warning signs and identifies three secondary-prevention behaviors (medication adherence, cardiac rehab referral, smoking cessation if applicable).

Interventions and rationales

Evaluation

• Did the patient receive PCI within the first-medical-contact-to-device window (or fibrinolysis within door-to-needle window)?
• Is troponin trending down? Any new arrhythmia?
• Did the patient verbalize recurrence warning signs and secondary prevention plan?

Care Plan #2 — Risk for Ineffective Cerebral Tissue Perfusion

Scenario. A 72-year-old woman with atrial fibrillation (on apixaban) is brought to ED by her husband at 11:15 AM. He says she was fine at breakfast at 8:30 AM, then around 10:30 he noticed her right-sided face droop and slurred speech. NIHSS 14. HR 88 irregularly irregular, BP 178/96. SpO₂ 95%. Last known well = 8:30 AM (about 2h 45min ago).

Diagnosis (NANDA-I 2024–2026)

Risk for Ineffective Cerebral Tissue Perfusion related to acute focal neurologic deficit consistent with embolic ischemic stroke, atrial fibrillation, and uncertain anticoagulation efficacy.

Goals

• Within 25 minutes of arrival, the patient completes non-contrast head CT to distinguish ischemic from hemorrhagic stroke.
• The patient receives appropriate reperfusion therapy if eligible per the stroke team — IV thrombolysis (alteplase or tenecteplase) and/or mechanical thrombectomy. Recent DOAC use (apixaban here) is a major thrombolysis eligibility issue — see interventions below.
• The patient maintains BP within the provider-specified range (typically permissive hypertension up to ~220/120 if not a thrombolysis candidate; lower thresholds apply for thrombolysis candidates per the 2026 AHA/ASA guideline).

Interventions and rationales

Evaluation

• Was non-contrast CT completed within 25 minutes?
• Was DOAC eligibility for IV thrombolysis evaluated by the stroke team?
• Did the patient receive appropriate reperfusion therapy (thrombolysis if eligible and/or thrombectomy for LVO) within the window?
• Is the NIHSS trending down? Any post-treatment hemorrhage?

Care Plan #3 — Risk for Ineffective Kidney Perfusion

Scenario. A 58-year-old man post-op day 1 from emergency colon resection for diverticular perforation. WBC 18, lactate 3.2, MAP 62 on 0.08 mcg/kg/min norepinephrine. Urine output last 4 hours: 30, 20, 15, 10 mL. Creatinine baseline 1.0, now 1.6 — meeting KDIGO stage 1 by creatinine criteria (rise ≥ 0.3 mg/dL in 48 h or 1.5–1.9× baseline in 7 d). UOP trend over 4 hours is concerning for evolving oliguria, but the KDIGO UOP criterion requires < 0.5 mL/kg/hr for ≥ 6 hours — continue hourly monitoring before staging by UOP.

Diagnosis (NANDA-I 2024–2026)

Risk for Ineffective Kidney Perfusion related to post-operative septic shock with vasopressor-dependent hypotension, hypovolemia from intraoperative losses, and potential nephrotoxic medication exposure.

Goals

• Within 4 hours, the patient maintains MAP ≥ 65 mm Hg, urine output ≥ 0.5 mL/kg/hr (or ≥ 30 mL/hr), and lactate trending down.
• Within 24 hours, creatinine plateaus or trends down; no further KDIGO AKI stage progression.
• The patient avoids nephrotoxic exposure throughout the perioperative period.

Interventions and rationales

Evaluation

• Did MAP and urine output meet targets?
• Has creatinine plateaued or improved?
• Was nephrotoxic exposure minimized?

Care Plan #4 — Ineffective Peripheral Tissue Perfusion

Scenario. A 68-year-old man with long-standing type 2 diabetes, hyperlipidemia, and 40-pack-year smoking history presents to clinic with bilateral calf pain when walking more than half a block, relieved by rest. Today, he reports the right foot has been “cold and weird” for 3 hours with a new sharp pain. On exam: right foot pale and cool compared to left, DP and PT pulses absent on the right (palpable on the left), capillary refill 5 seconds, decreased sensation in the right forefoot.

Diagnosis (NANDA-I 2024–2026)

Ineffective Peripheral Tissue Perfusion related to acute right lower extremity arterial occlusion superimposed on chronic peripheral artery disease, as evidenced by absent DP and PT pulses on the right, pale and cool right foot, capillary refill 5 seconds, and patient-reported sudden onset of pain and sensory change.

(This is the one NANDA perfusion diagnosis that remains an “actual” — not “risk for” — when defining characteristics are present.)

Goals

• Within 30 minutes, the patient receives vascular evaluation for possible acute limb ischemia.
• Definitive vascular intervention is initiated as soon as feasible based on limb viability, Rutherford classification, and specialist assessment. Delays beyond ~4–6 hours of ischemia time meaningfully increase the risk of irreversible neuromuscular injury and limb loss, but revascularization timing is specialist-driven — not a flat clock.
• Pre-discharge, the patient verbalizes lifestyle modifications and medication adherence (antiplatelet, statin, smoking cessation, glycemic control).

Interventions and rationales

Evaluation

• Was vascular surgery consulted within the urgent timeframe?
• Has limb viability been preserved (pulses returning post-intervention, perfusion improving)?
• Did the patient verbalize and accept the long-term prevention plan?

Care Plan #5 — Risk for Ineffective Gastrointestinal Perfusion

Scenario. A 79-year-old woman with chronic atrial fibrillation (CHA₂DS₂-VASc 5; off anticoagulation for the past month after a fall workup) presents with sudden severe abdominal pain that started 3 hours ago. Pain rated 10/10, diffuse. On exam, abdomen is soft with minimal tenderness — “pain out of proportion to exam.” Lactate 5.8 mmol/L. HR 112, BP 102/68. CT angio pending.

Diagnosis (NANDA-I 2024–2026)

Risk for Ineffective Gastrointestinal Perfusion related to suspected acute mesenteric ischemia from cardioembolic occlusion (atrial fibrillation off anticoagulation), elevated lactate, and pain pattern characteristic of mesenteric ischemia.

Goals

• Within 60 minutes, the patient completes CT angio of the abdomen and receives vascular surgery / GI evaluation.
• Within 6 hours, the patient receives definitive intervention (embolectomy, thrombolysis, bypass, or bowel resection per provider) if mesenteric ischemia is confirmed.
• The patient maintains hemodynamic stability and lactate trends down with treatment.

Interventions and rationales

Evaluation

• Was CT angio completed and surgery / GI consulted within the urgent window?
• Did lactate trend down with intervention?
• Is the patient hemodynamically stable post-intervention?

Stroke at the bedside (BE FAST, NIHSS, treatment windows)

A quick bedside reference for nursing students:

Recognize — BE FAST

• Balance — sudden loss of balance / coordination
• Eyes — sudden vision change, double vision, monocular blindness
• Face — facial droop
• Arm — arm drift / weakness
• Speech — slurred speech, word-finding difficulty, can’t repeat a sentence
• Time — note the time of symptom onset (or last known well); call for help immediately

Key actions in the first 25 minutes

• Document last known well time precisely — this is what drives the tPA / thrombectomy window
• Activate the stroke alert; coordinate with neurology and CT
• Non-contrast head CT FIRST — exclude hemorrhage before any aspirin or anticoagulation
• NIHSS assessment per facility tool
• IV access, labs (CBC, BMP, coags, troponin), ECG
• Keep NPO until swallow screen passed

Treatment windows (per the 2026 AHA/ASA acute ischemic stroke guideline)

• IV thrombolysis (alteplase or tenecteplase per stroke-team protocol): eligible patients with disabling acute ischemic stroke may receive IV thrombolysis within 4.5 hours of last known well. Selected patients with unknown onset or 4.5–9 hours from onset may be considered using advanced imaging criteria (e.g., MRI mismatch).
• Mechanical thrombectomy: considered for eligible large-vessel occlusion patients, including selected patients up to 24 hours based on imaging and occlusion location (large-core and basilar-artery-occlusion patients may be eligible).
• Recent DOAC use (apixaban, rivaroxaban, dabigatran, edoxaban) within ~48 hours is a major thrombolysis exclusion unless lab evidence suggests subtherapeutic anticoagulation. Document last DOAC dose and renal function. DOAC exposure is less restrictive for mechanical thrombectomy than for IV thrombolysis.

Hemorrhagic vs ischemic — CT first. Aspirin or anticoagulation in a hemorrhagic stroke worsens bleeding. Every “stroke alert” patient gets non-contrast head CT before any antithrombotic therapy.

Aspirin timing pearl. When IV thrombolysis is NOT given, aspirin is commonly initiated within 24–48 hours of ischemic stroke onset per stroke-team protocol. When IV thrombolysis IS given, aspirin (and other antiplatelet therapy) is typically delayed until ~24 hours later, after follow-up imaging confirms no hemorrhagic conversion.

Acute limb ischemia (the 6 Ps)

A limb-threatening vascular emergency:

• Pain (sudden, severe)
• Pallor
• Pulselessness
• Paresthesia
• Paralysis
• Poikilothermia (cold limb)

Time to revascularization matters — irreversible muscle damage starts at 4–6 hours; peripheral nerve damage can begin even sooner. Coordinate vascular surgery immediately. Heparin per provider. Do not elevate the affected limb (worsens arterial flow); position at heart level or slightly dependent.

Escalation red flags

Discharge and patient teaching

Practice question

The nurse is caring for a patient who arrived 90 minutes ago with sudden right-sided weakness and slurred speech (NIHSS 12). Non-contrast head CT showed no hemorrhage. Last known well was 2 hours ago. Which nursing actions are appropriate? (Select all that apply.)

• A. Administer aspirin 325 mg immediately
• B. Prepare for IV tPA per neurology
• C. Place the patient NPO until swallow screen is completed
• D. Document last known well in the chart
• E. Lower the patient’s BP to < 140/90 with IV labetalol

Answer: B, C, D.

• B — within the IV thrombolysis window (up to 4.5 h from last known well per the 2026 AHA/ASA guideline); CT excluded hemorrhage; preparing for IV thrombolysis (alteplase or tenecteplase) per stroke team is appropriate. (In the real clinical encounter, the nurse would also verify recent DOAC use, renal function, and other eligibility criteria.)
• C — stroke significantly increases aspiration risk; NPO until swallow screen is mandatory.
• D — last known well is the time-stamp that drives all treatment-window decisions.
• A — aspirin is held for IV thrombolysis candidates; it can be given after a stroke when thrombolysis is excluded or, when thrombolysis is given, typically delayed ~24 hours per stroke protocol.
• E is incorrect. Do not aggressively lower BP to < 140/90 in acute ischemic stroke. Follow the stroke-team BP target. BP must be within the thrombolysis threshold (SBP < 185 / DBP < 110) before IV thrombolysis is initiated, but intensive systolic BP lowering to < 140 mm Hg is not recommended — it has been associated with worse outcomes in recent evidence after thrombolysis or endovascular therapy.

FAQs

What is the most current nursing diagnosis for ineffective tissue perfusion?

Current NANDA-I editions emphasize system-specific perfusion-related diagnoses rather than a single generic label: Risk for Decreased Cardiac Tissue Perfusion, Risk for Ineffective Cerebral Tissue Perfusion, Ineffective Peripheral Tissue Perfusion (typically used as the “actual” label when defining characteristics are present), Risk for Ineffective Peripheral Tissue Perfusion, Risk for Ineffective Kidney Perfusion, and Risk for Ineffective Gastrointestinal Perfusion. Verify the exact label, definition, and defining characteristics against your licensed NANDA-I 2024–2026 text before using these for graded paperwork.

What is the BE FAST mnemonic for stroke?

Balance, Eyes, Face, Arm, Speech, Time. It’s the patient-facing recognition tool — sudden onset of any of these warrants 911 activation. Document the time of symptom onset (or last known well) immediately; treatment windows are time-stamped from that.

What’s the difference between IV thrombolysis and mechanical thrombectomy?

IV thrombolysis (alteplase or tenecteplase per stroke-team protocol) dissolves the clot pharmacologically. Per the 2026 AHA/ASA acute ischemic stroke guideline, eligible patients may receive IV thrombolysis within 4.5 hours of last known well, with select patients considered up to 9 hours using advanced imaging criteria. Mechanical thrombectomy is a catheter-based procedure where the clot is physically extracted; it’s available for select large-vessel occlusion patients up to 24 hours from last known well when imaging shows salvageable brain. Both require non-contrast CT first to rule out hemorrhage. Recent DOAC use (within ~48 hours) is a major IV thrombolysis exclusion unless lab evidence suggests subtherapeutic anticoagulation; it’s less restrictive for thrombectomy.

What is the target reperfusion time for STEMI?

Target first-medical-contact-to-device ≤ 90 minutes for STEMI managed with primary PCI in a PCI-capable system per the 2025 ACC/AHA ACS guideline. If timely PCI cannot be achieved and there are no contraindications, fibrinolysis may be used per protocol with a door-to-needle goal ≤ 30 minutes.

What are the 6 Ps of acute limb ischemia?

Pain, Pallor, Pulselessness, Paresthesia, Paralysis, Poikilothermia (cold limb). They form a useful mnemonic but are not a checklist — escalate on clinical suspicion even before all six are present. Acute limb ischemia is a vascular emergency; irreversible muscle damage begins within ~4–6 hours of ischemia time.

What’s a normal lactate, and what does an elevated lactate mean?

Normal lactate is < 2 mmol/L. Levels > 2 mmol/L should prompt reassessment in clinical context. Lactate ≥ 4 mmol/L is a high-risk finding often seen in shock or severe illness but is not specific for hypoperfusion — interpret with the perfusion exam, hemodynamics, medications, liver function, recent exertion/seizures, sepsis, and regional ischemia in mind. Trending matters more than a single value.

Related resources

• Nursing Diagnosis — full NANDA-I guide
• Nursing Interventions — independent, dependent, collaborative interventions explained
• Nursing Care Plan Template — fillable template you can adapt for any patient
• Nursing Process — the 5-step framework refresher
• ADPIE — Assessment, Diagnosis, Planning, Implementation, Evaluation
• Decreased Cardiac Output Nursing Diagnosis — companion care plan for the pump side of perfusion
• Anemia Nursing Care Plan — companion care plan for the oxygen-carrying side of perfusion

References

1. Herdman TH, Kamitsuru S, Lopes CT (eds). NANDA International Nursing Diagnoses: Definitions and Classification, 13th ed., 2024–2026. Thieme. https://nanda.org/
2. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes. Journal of the American College of Cardiology. https://www.jacc.org/doi/10.1016/j.jacc.2024.10.001
3. American Heart Association / American Stroke Association. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke (AHA/ASA). Stroke. https://www.ahajournals.org/journal/str
4. Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 AHA/ASA Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage. Stroke. https://www.ahajournals.org/doi/10.1161/STR.0000000000000407
5. KDIGO. Clinical Practice Guideline for Acute Kidney Injury. https://kdigo.org/guidelines/acute-kidney-injury/
6. Gornik HL, Aronow HD, Goodney PP, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease. Journal of the American College of Cardiology / Circulation. https://www.jacc.org/doi/10.1016/j.jacc.2024.02.013
7. Björck M, Koelemay M, Acosta S, et al. European Society for Vascular Surgery Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. European Journal of Vascular and Endovascular Surgery. https://www.ejves.com/article/S1078-5884(19)32428-9/fulltext
8. Bala M, Kashuk J, Moore EE, et al. Acute Mesenteric Ischemia: Guidelines of the World Society of Emergency Surgery. World Journal of Emergency Surgery. https://wjes.biomedcentral.com/articles/10.1186/s13017-022-00443-x
9. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine. https://journals.lww.com/ccmjournal/Fulltext/2021/11000/Surviving_Sepsis_Campaign__International.21.aspx
10. National Library of Medicine (NCBI Bookshelf). Tissue Perfusion. https://www.ncbi.nlm.nih.gov/books/NBK537336/
11. American Heart Association. Stroke Symptoms and Recognition — BE FAST. https://www.stroke.org/en/about-stroke/stroke-symptoms

Source notes. NANDA-I diagnoses, definitions, defining characteristics, and related / risk factors should be verified in the licensed NANDA-I 2024–2026 text before clinical documentation. ACC/AHA, AHA/ASA stroke, KDIGO, and Surviving Sepsis Campaign guidelines are updated periodically — cite the most current edition. Stroke treatment windows, ACS reperfusion targets, and AKI staging may be updated as evidence evolves.